Synsorb Biotech, Inc.

David J Rafter

Bradley G Thompson

Glen D Armstrong

Terrance P Klassen

Hermy Lior

Peter C Rowe

Paul R Goodyer

Francois Auclair

Elaine Orrbine

George A Wells

Peter N McLaine

Andrew M MacKenzie

Robert Murray Ratcliffe

This invention relates to the treatment of diarrhea and related conditions caused by pathogenic,infection. More specifically, this invention is drawn to the unexpected discovery that by administering a composition which binds and removes the shiga like toxins (SLT) produced by pathogenic,whenever an antibiotic is administered, improved treatment is provided. Novel compositions containing both antibiotic and toxin binding composition and methods of treatment which use simultaneous administration toxin binding composition whenever antibiotic is administered are provided. These compositions and methods kill the enteric,organisms which produce the conditions and neutralize the SLT produced by the organisms and/or released from the organisms when they are killed. Thus, these compositions and methods are better able to ameliorate the symptoms of the infection and inhibit progression of this infection into hemolytic uremic syndrome (HUS) than conventional treatment.

Compounds and methods for the treatment of bacterial dysentery using antibiotics and toxin binding oligosaccharide compositions

Disclosed are methods for the neutralization of shiga-like toxins (SLT) associated with enteric E. coli infection which methods inhibit progression of this infection into hemolytic uremic syndrome (HUS).

Treatment of bacterial dysentery

Growing community of inventors

Calgary, Canada

David J Rafter